ConductScience.org, home

Paper39882147

Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort Study.

Chattopadhyay A and 7 others. Womens Health Rep (New Rochelle), 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort Study. Papers, record 39882147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39882147

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Predicting Survival Outcomes for Patients with Ovarian Cancer Using National Cancer Registry Data from Taiwan: A Retrospective Cohort Study.
PubMed
Journal
Womens Health Rep (New Rochelle)
PubMed
Year
2025
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2025-03-25
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chattopadhyay AAmrita
2Wu YTYa-Ting
3Chan HCHan-Ching
4Kang YTYi-Ting
5Chiang YCYing-Cheng
6Chiang CJChun-Ju
7Lee WCWen-Chung
8Lu TPTzu-Pinhttps://orcid.org/0000-0003-3697-0386

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127315065Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?Curr Treat Options Oncol2016https://conductscience.org/library/papers/27315065PubMed
221716157Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.Pathology2011https://conductscience.org/library/papers/21716157PubMed
335117197Development of a nomogram to predict prognosis in ovarian cancer: a SEER-based study.Transl Cancer Res2020https://conductscience.org/library/papers/35117197PubMed
424167670Trends in incidence and survival outcome of epithelial ovarian cancer: 30-year national population-based registry in Taiwan.J Gynecol Oncol2013https://conductscience.org/library/papers/24167670PubMed
536233339Molecular Biomarkers for the Early Detection of Ovarian Cancer.Int J Mol Sci2022https://conductscience.org/library/papers/36233339PubMed
629718305Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.J Natl Cancer Inst2019https://conductscience.org/library/papers/29718305PubMed
728931403Racial health disparities in ovarian cancer: not just black and white.J Ovarian Res2017https://conductscience.org/library/papers/28931403PubMed
810217079Screening for ovarian cancer: a pilot randomised controlled trial.Lancet1999https://conductscience.org/library/papers/10217079PubMed
923256068Intraoperative image-guided surgery for ovarian cancer.Quant Imaging Med Surg2012https://conductscience.org/library/papers/23256068PubMed
1029579127Prognostic factors in epithelial ovarian cancer: A population-based study.PLoS One2018https://conductscience.org/library/papers/29579127PubMed
1129572027A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.Gynecol Oncol2018https://conductscience.org/library/papers/29572027PubMed
1230773272Taiwan's Nationwide Cancer Registry System of 40 years: Past, present, and future.J Formos Med Assoc2019https://conductscience.org/library/papers/30773272PubMed
1325525571Epithelial ovarian cancer: An overview.World J Transl Med2014https://conductscience.org/library/papers/25525571PubMed
1431254796Clear differences in ovarian cancer incidence and trends by ethnicity among Asian Americans.Cancer Epidemiol2019https://conductscience.org/library/papers/31254796PubMed
1519552940Ovarian carcinoma pathology and genetics: recent advances.Hum Pathol2009https://conductscience.org/library/papers/19552940PubMed
1615211606Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.Stat Med2004https://conductscience.org/library/papers/15211606PubMed
1711920552Ethnic differences in survival among women with ovarian carcinoma.Cancer2002https://conductscience.org/library/papers/11920552PubMed
1836968229Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019.Cancer Res Commun2023https://conductscience.org/library/papers/36968229PubMed
1915241833The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.Cancer2004https://conductscience.org/library/papers/15241833PubMed
2012839961The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.Cancer Res2003https://conductscience.org/library/papers/12839961PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39882147

GET https://conductscience.org/api/papers/v1/39882147/references?page=2